Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Champs Meet Again in Nassau
- Suddenbreakingnews Works, Bound for Belmont
- Nyquist Out of Belmont Stakes with Fever
- Beholder Fires Bullet, Ready to Rumble
- Barretts Sale Features Wide Selection
- Havre de Grace Half Sister Wins at Delaware
- Nyquist Spikes Fever; Did Not Ship to Belmont
- Strangles Leads to ThistleDown Quarantine
- Derby Runner-Up Commanding Curve Retired
- An Early Look at the Belmont Stakes